Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00270894
Status:
COMPLETED
Last Update Posted:
2012-03-20
First Post:
2005-12-28
Brief Title:
Neoadjuvant Chemotherapy Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Accelerated Community Oncology Research Network
Organization Data
Organization:
Accelerated Community Oncology Research Network
Class:
OTHER
Study ID:
ACORN ALSSNBC0401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Accelerated Community Oncology Research Network
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |